DA32 Life Science Tech Acquisition Corp. (DALS) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in New York City, NY, United States. The current CEO is Steven Kafka.
DALS has IPO date of 2021-07-28, listed on the NASDAQ Capital Marke, a market capitalization of $264.2M.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
